> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lilly Recalls 1 Lot of Glucagon Emergency Kit
- URL: https://www.fdaweb.com/lilly-recalls-1-lot-of-glucagon-emergency-kit/
- Published: 2021-09-27T12:00:00.000Z
- Updated: 2026-09-14T17:16:17.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150223

Eli Lilly has recalled one lot of its Glucagon Emergency Kit for Low Blood Sugar (glucagon for injection, 1 mg per vial; diluent for glucagon, 1 mL syringe) after receiving a product complaint reporting that a vial of glucagon was in liquid form instead of the powder form. A company investigation found that the liquid in the glucagon vial could be related to the manufacturing process, according to a recall notice. “The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency,” it says.

The Glucagon Emergency Kit is used as an anti-hypoglycemic agent and a gastrointestinal motility inhibitor indicated for treating severe hypoglycemia in pediatric and adult patients with diabetes mellitus. Severe hypoglycemia in patients with diabetes, if not reversed, can potentially cause adverse health consequences ranging from transient, minor complaints to neurological damage, seizures, and even death if not promptly treated, the recall notice says.